Agilon Health (AGL) Cash & Current Investments (2020 - 2026)

Agilon Health (AGL) has reported Cash & Current Investments for 7 consecutive years, with $231.4 million the latest figure, recorded in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $231.4 million, down 36.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $231.4 million (down 36.96% YoY), and the FY2025 annual result was $285.1 million, down 28.71% from the prior year.
• Cash & Current Investments was $231.4 million for Q1 2026 at Agilon Health, down from $285.1 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $1.0 billion in Q1 2022 and troughed at $231.4 million in Q1 2026.
• Average Cash & Current Investments over 5 years is $552.7 million, with a median of $419.1 million recorded in 2024.
• Year-over-year, Cash & Current Investments jumped 870.43% in 2022 and slumped 48.69% in 2024.
• Over 5 years, Cash & Current Investments stood at $877.2 million in 2022, then tumbled by 44.33% to $488.3 million in 2023, then fell by 18.1% to $400.0 million in 2024, then declined by 28.71% to $285.1 million in 2025, then fell by 18.84% to $231.4 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $231.4 million in Q1 2026, $285.1 million in Q4 2025, and $310.9 million in Q3 2025.